Drug Search Results

Tesaglitazar

Alternative Names: tesaglitazar
Latest Update: 2024-04-16
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PPAR-a Agonist,PPAR-g Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: AstraZeneca
Company Location: CAMBRIDGE X0 CB2 0AA
Company CEO: Pascal Soriot
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tesaglitazar

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Type 2 Diabetes

Phase 2: Type 2 Diabetes|Insulin Resistance

Trial	Phase	Trial Status	Disease	Primary Completion Date
GALLANT 4	P3	Completed	Type 2 Diabetes	2008-05-19
GALLANT 7	P3	Completed	Type 2 Diabetes	2007-03-14
GALLEX 1	P3	Completed	Type 2 Diabetes	2007-02-28
GALLANT 14	P3	Completed	Type 2 Diabetes	2007-02-26

Recent News Events

Date	Type	Title
04/16/2024	PubMed	PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis.
01/01/2024	PubMed	PPARα/γ synergism activates UCP1-dependent and -independent thermogenesis and improves mitochondrial dynamics in the beige adipocytes of high-fat fed mice.
04/03/2023	PubMed	Integrated analysis of multi-omics data reveals T cell exhaustion in sepsis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions